Details

EULAR study group on 'MHC-I-opathy' : identifying disease-overarching mechanisms across disciplines and borders
ID Kuiper, Jonas Jan Willem (Author), ID Vidović Valentinčič, Nataša (Author), ID Turkstra, Franktien (Author), et al.

.pdfPDF - Presentation file, Download (790,03 KB)
MD5: 75B538544B87423EF79E1F3C4B6B5998
URLURL - Source URL, Visit https://ard.eular.org/article/S0003-4967(24)00398-4/fulltext This link opens in a new window

Abstract
The 'MHC-I (major histocompatibility complex class I)-opathy' concept describes a family of inflammatory conditions with overlapping clinical manifestations and a strong genetic link to the MHC-I antigen presentation pathway. Classical MHC-I-opathies such as spondyloarthritis, Behçet's disease, psoriasis and birdshot uveitis are widely recognised for their strong association with certain MHC-I alleles and gene variants of the antigen processing aminopeptidases ERAP1 and ERAP2 that implicates altered MHC-I peptide presentation to CD8$^{+}$ T cells in the pathogenesis. Progress in understanding the cause and treatment of these disorders is hampered by patient phenotypic heterogeneity and lack of systematic investigation of the MHC-I pathway. Here, we discuss new insights into the biology of MHC-I-opathies that strongly advocate for disease-overarching and integrated molecular and clinical investigation to decipher underlying disease mechanisms. Because this requires transformative multidisciplinary collaboration, we introduce the EULAR study group on MHC-I-opathies to unite clinical expertise in rheumatology, dermatology and ophthalmology, with fundamental and translational researchers from multiple disciplines such as immunology, genomics and proteomics, alongside patient partners. We prioritise standardisation of disease phenotypes and scientific nomenclature and propose interdisciplinary genetic and translational studies to exploit emerging therapeutic strategies to understand MHC-I-mediated disease mechanisms. These collaborative efforts are required to address outstanding questions in the etiopathogenesis of MHC-I-opathies towards improving patient treatment and prognostication.

Language:English
Keywords:psoriatic arthritis, Behçet syndrome, immune system diseases, ankylosing spondylitis
Work type:Article
Typology:1.02 - Review Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2023
Number of pages:Str. 887-896
Numbering:Vol. 82, iss. 7
PID:20.500.12556/RUL-182309 This link opens in a new window
UDC:616-002
ISSN on article:0003-4967
DOI:10.1136/ard-2022-222852 This link opens in a new window
COBISS.SI-ID:275985411 This link opens in a new window
Publication date in RUL:07.05.2026
Views:381
Downloads:222
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Annals of the Rheumatic Diseases
Shortened title:Ann. Rheum. Dis.
Publisher:British Medical Association
ISSN:0003-4967
COBISS.SI-ID:24967936 This link opens in a new window

Licences

License:CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:http://creativecommons.org/licenses/by-nc/4.0/
Description:A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.

Secondary language

Language:Slovenian
Keywords:psoriatični artritis, Behçetov sindrom, bolezni imunskega sistema, ankilozirajoči spondilitis

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back